A detailed history of Brinker Capital Investments, LLC transactions in Vericel Corp stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 29,715 shares of VCEL stock, worth $1.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,715
Previous 28,172 5.48%
Holding current value
$1.7 Million
Previous $654,000 19.57%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$17.65 - $27.37 $27,233 - $42,231
1,543 Added 5.48%
29,715 $782,000
Q3 2022

Nov 01, 2022

BUY
$22.62 - $32.54 $222,173 - $319,607
9,822 Added 53.53%
28,172 $654,000
Q2 2022

Jul 18, 2022

SELL
$22.88 - $39.45 $67,541 - $116,456
-2,952 Reduced 13.86%
18,350 $462,000
Q1 2022

May 16, 2022

BUY
$31.69 - $43.29 $675,060 - $922,163
21,302 New
21,302 $814,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.